DNLI

18.4401.32%
DA

Dana Andersen

Chief Technical and Manufacturing Officer

Dr. Dana Andersen has been Chief Technical and Manufacturing Officer at Denali Therapeutics Inc. since August 7, 2018. Dr. Andersen joined Denali August 7, 2018 from Genentech, where he served in various roles for nearly 23 years, working most recently as Vice President and Global Head of Technical Development Project & Portfolio Management. Prior to this role, he was Vice President of Pharmaceutical Development and held numerous leadership roles spanning biologics manufacturing process development at Genentech. Dr. Andersen is a fellow of the American Institute for Medical and Biological Engineering and received a B.S. from the University of Colorado at Boulder, and a M.S. and Ph.D. from Stanford University, all in chemical engineering with a focus on biological systems.

Positions